Tafluprost Solution/ Drops
Product Images NDC 42571-264

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tafluprost (NDC 42571-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tafluprost-ampule.jpg (Tafluprost Ampule)

Tafluprost-ampule.jpg (Tafluprost Ampule)
Tafluprost Ophthalmic Solution is a medication designed for use in the eye. It is made in India. The remaining text is not intelligible or recognizable and may be a scanning error.*
FDA Label Image

Tafluprost-carton.jpg (Tafluprost Carton)

Tafluprost-carton.jpg (Tafluprost Carton)
Tafluprost Ophthalmic Solution is a prescription medication used for topical application in the eye. It comes in 15 single-dose containers, and each container contains 0.3 mL of solution. The solution must be refrigerated between 2°C to 8°C or 36°F to 46°F. It is important to discard the opened container with any remaining content immediately after use. The usual dosage is one drop in the affected eye(s) once daily in the evening. The medication should be used immediately after opening the container. If the prescription is not received within two days of the dispensing date, the dispensing pharmacy should be contacted. During shipment, Tafluprost Ophthalmic Solution can be maintained up to 40°C (104°F) for a maximum of two days. The medication is manufactured by Micro Labs Limited, and the package includes an unvarnished area as per the DGFT.*
FDA Label Image

Tafluprost-figure1.jpg (Tafluprost Figure1)

FDA Label Image

Tafluprost-figure2.jpg (Tafluprost Figure2)

FDA Label Image

Tafluprost-figure3.jpg (Tafluprost Figure3)

FDA Label Image

Tafluprost-figure4.jpg (Tafluprost Figure4)

FDA Label Image

Tafluprost-pouch.jpg (Tafluprost Pouch)

Tafluprost-pouch.jpg (Tafluprost Pouch)
Tafluprost Ophthalmic Solution is a prescription medication used for topical application in the eye. Each package contains 15 single-dose containers of 0.3mL each, which are preservative-free and sterile. The active ingredient in this solution is Tafluprost 0.0015% (4.5 mcg per single-dose container). Other inactive ingredients are also listed. The medicine needs to be stored refrigerated at 2° to 8°C (36° to 46°F) and after the pouch is opened, the single-dose containers can be stored in the opened foil pouch for up to 30 days at room temperature 20° to 25°C (68° to 77°F), and protected from moisture. The usual dose is one drop in the affected eye(s) once daily in the evening. Finally, the medicine should be used immediately after opening the container and the container with the remaining contents should be discarded promptly.*
FDA Label Image

Tafluprost-str.jpg (Tafluprost Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.